Amiodarone Hydrochloride



Indications and Reactions:

Role Indications Reactions
Primary
Atrial Fibrillation 27.4%
Product Used For Unknown Indication 18.9%
Atrial Flutter 9.1%
Drug Use For Unknown Indication 6.6%
Hypertension 5.4%
Arrhythmia 5.0%
Ventricular Tachycardia 3.6%
Tachyarrhythmia 3.0%
Gout 2.8%
Myocardial Infarction 2.6%
Cardiac Disorder 2.2%
Heart Rate Irregular 2.0%
Anticoagulant Therapy 1.6%
Supplementation Therapy 1.6%
Supraventricular Tachycardia 1.6%
Prophylaxis 1.4%
Ventricular Arrhythmia 1.4%
Arrhythmia Prophylaxis 1.2%
Essential Hypertension 1.2%
Insomnia 1.2%
Infusion Site Phlebitis 13.4%
Pulmonary Toxicity 10.6%
Phlebitis 10.1%
Hyperthyroidism 6.7%
Toxicity To Various Agents 6.7%
Tremor 6.1%
Drug Interaction 5.6%
Neurotoxicity 5.6%
Neuromyopathy 5.0%
Off Label Use 3.9%
Pneumonia 3.9%
Ventricular Tachycardia 3.4%
Interstitial Lung Disease 2.8%
Pulmonary Oedema 2.8%
Electrocardiogram Qt Prolonged 2.2%
Injection Site Phlebitis 2.2%
Keratopathy 2.2%
Lung Disorder 2.2%
Respiratory Failure 2.2%
Ventricular Fibrillation 2.2%
Secondary
Drug Use For Unknown Indication 23.0%
Atrial Fibrillation 17.4%
Product Used For Unknown Indication 13.0%
Hypertension 5.7%
Ventricular Tachycardia 5.7%
Arrhythmia 4.4%
Ventricular Fibrillation 4.3%
Cardiac Failure 3.4%
Atrial Flutter 3.2%
Angina Pectoris 2.9%
Hypothermia 2.9%
Septic Shock 1.9%
Spinal Osteoarthritis 1.6%
Acute Myocardial Infarction 1.6%
Essential Hypertension 1.6%
Cardio-respiratory Arrest 1.5%
Coronary Artery Disease 1.5%
Heart Rate Irregular 1.5%
Ventricular Tachyarrhythmia 1.5%
Diabetes Mellitus 1.4%
Ventricular Extrasystoles 8.2%
Syncope 7.1%
Ventricular Tachycardia 6.6%
Electrocardiogram Qt Prolonged 5.6%
Liver Disorder 5.6%
Respiratory Failure 5.6%
Rhabdomyolysis 5.6%
Torsade De Pointes 5.6%
Infusion Site Phlebitis 5.1%
Phlebitis 5.1%
Sedation 5.1%
Ventricular Fibrillation 5.1%
Renal Failure Acute 4.6%
Drug Interaction 4.1%
Hypothyroidism 4.1%
Parkinsonism 4.1%
Thrombocytopenia 3.6%
Cardiac Arrest 3.1%
Multi-organ Failure 3.1%
Myositis 3.1%
Concomitant
Drug Use For Unknown Indication 26.0%
Product Used For Unknown Indication 22.6%
Hypertension 8.5%
Atrial Fibrillation 6.4%
Cardiac Failure Chronic 5.6%
Cardiac Failure 5.2%
Cardiac Disorder 3.4%
Diabetes Mellitus 3.0%
Prophylaxis 2.8%
Arrhythmia 2.6%
Type 2 Diabetes Mellitus 2.4%
Rheumatoid Arthritis 2.1%
Hyperlipidaemia 1.3%
Myocardial Infarction 1.2%
Angina Pectoris 1.2%
B-cell Lymphoma 1.2%
Univentricular Heart 1.2%
Coronary Artery Disease 1.1%
Osteoporosis 1.1%
Blood Cholesterol Increased 1.0%
Renal Failure Acute 9.8%
Vomiting 9.3%
Ventricular Tachycardia 8.2%
Rhabdomyolysis 5.7%
Ventricular Fibrillation 5.7%
Death 5.2%
Stevens-johnson Syndrome 5.2%
Thrombocytopenia 5.2%
Atrial Fibrillation 4.6%
Syncope 4.6%
Urinary Tract Infection 4.6%
Hypoglycaemia 4.1%
White Blood Cell Count Decreased 4.1%
Arrhythmia 3.6%
Lung Disorder 3.6%
Platelet Count Decreased 3.6%
Weight Decreased 3.6%
Bradycardia 3.1%
Cerebrovascular Accident 3.1%
Renal Impairment 3.1%
Interacting
Atrial Flutter 11.7%
Renal Failure Chronic 9.5%
Pneumonia 8.8%
Ventricular Tachycardia 8.8%
Atrial Fibrillation 8.0%
Ill-defined Disorder 8.0%
Drug Use For Unknown Indication 7.3%
Antiplatelet Therapy 4.4%
Product Used For Unknown Indication 4.4%
Pulmonary Embolism 4.4%
Pain 3.6%
Essential Hypertension 2.9%
Hyperlipidaemia 2.9%
Sleep Disorder 2.9%
Anticoagulant Therapy 2.2%
Cardiac Disorder 2.2%
Hypertension 2.2%
Pain In Extremity 2.2%
Supraventricular Tachycardia 2.2%
Acute Myocardial Infarction 1.5%
Drug Interaction 20.5%
Cardioactive Drug Level Increased 10.3%
Blood Creatinine Increased 7.7%
Myopathy 7.7%
Retroperitoneal Haematoma 7.7%
Alanine Aminotransferase Increased 5.1%
Hypersensitivity 5.1%
Torsade De Pointes 5.1%
Electrolyte Imbalance 2.6%
Hepatic Steatosis 2.6%
Hepatitis Cholestatic 2.6%
Hypoaesthesia 2.6%
Melaena 2.6%
Periorbital Oedema 2.6%
Rash 2.6%
Renal Cell Carcinoma 2.6%
Somnolence 2.6%
Therapeutic Response Unexpected With Drug Substitution 2.6%
Unresponsive To Stimuli 2.6%
Urinary Incontinence 2.6%